Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case-control study

European Respiratory Journal

Volumn 47, Issue 5, 2016, Pages 1575-1577

  Albrecht, Christiane ^a   Ringshausen, Felix ^a   Ott, Sebastian ^b   Wagner, Dirk ^c   Rademacher, Jessica ^a   Schneider, Michael ^a   Welte, Tobias ^a   Pletz, Mathias W ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c Dept of Infectious Diseases and Center for Chronic Immunodeficiency ^*  (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; BACTERIUM DETECTION; BODY MASS; BURKHOLDERIA CEPACIA; CASE CONTROL STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM GORDONAE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; YOUNG ADULT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM;

ADULT; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; HUMANS; MYCOBACTERIUM;

EID: 84969793265     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01239-2015     Document Type: Letter

References (11)

1. Mirsaeidi M, Farnia P, Sadikot R, et al. Nontuberculous mycobacteria: epidemiologic, mycobacteriologic, and clinical aspects. Biomed Res Int 2015; 2015: 523697.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
3. Olivier KN, Weber DJ, Lee JH, et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167: 835-840.
4. Esther CR Jr, Esserman DA, Gilligan P, et al. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010; 9: 117-123.
5. Esther CR Jr, Henry MM, Molina PL, et al. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005; 40: 39-44.
6. Forslow U, Geborek A, Hjelte L, et al. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta paediatrica 2003; 92: 910-915.
7. Qvist T, Gilljam M, Jonsson B, et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros 2015; 14: 46-52.
8. Lewinsohn DA, Gennaro ML, Scholvinck L, et al. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis 2004; 8: 658-674.
9. Uyan ZS, Ersu R, Oktem S, et al. Mycobacterium abscessus infection in a cystic fibrosis patient: A difficult to treat infection. Int J Tuberc Lung Dis 2010; 14: 250-251.
10. Qvist T, Pressler T, Thomsen VO, et al. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: A retrospective analysis in a Danish patient population. Transplant Proc 2013; 45: 342-345.
11. Martiniano SL, Sontag MK, Daley CL, et al. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 2014; 11: 36-44.